SM
TOVX icon

Sabby Management’s Theriva Biologics TOVX Stock Holding History

Sabby Management’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-308
Closed -$25K – 136
2020
Q1 		$25K Sell
308
-2,441
-89% -$278K 0.09% 79
2019
Q4 		$348K Sell
2,749
-593
-18% -$63.1K 1.27% 40
2019
Q3 		$379K Sell
3,342
-273
-8% -$33K 1.06% 50
2019
Q2 		$497K Buy
3,615
+875
+32% +$126K 1.3% 32
2019
Q1 		$465K Sell
2,740
-1,730
-39% -$287K 1.44% 34
2018
Q4 		$626K Buy
+4,470
New +$1.06M 0.58% 44
2017
Q3 		– Sell
-19
Closed -$95K – 235
2017
Q2 		$95K Sell
19
-143
-88% -$712K 0.04% 195
2017
Q1 		$892K Sell
162
-185
-53% -$1.29M 0.62% 139
2016
Q4 		$2.31M Buy
+347
New +$3.56M 0.7% 92

Other funds holding TOVX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return